Cortex Pharmaceuticals, Inc. · Irvine, CA United States (OTC: CORX)
| 15231 Barranca Pkwy. | Phone: 949-727-3157 |
| Irvine, CA | Fax: 949-727-3657 |
| 92618 | |
| United States | 
Map This Company |
Cortex Pharmaceuticals, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Cortex Pharmaceuticals develops drugs to treat neurodegenerative and psychiatric disorders. Its research focuses on the AMPA receptor, which facilitates communication between nerve cells; the firm's Ampakine compounds may enhance this receptor's activity. Cortex's tends to develop candidates and then license the technologies to larger firms for diseases that require clinical and commercialization infrastructure to develop drugs for large markets (Alzheimer's disease, for instance). In turn, it will focus its internal research efforts on developing more compounds for niche markets, which require a smaller sales organization and more limited clinical trials.
Cortex Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - OTC: CORX Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 6 |
Executives
21 executives listed for Cortex Pharmaceuticals, Inc.'s Irvine, CA location.
| Chairman | Roger Stoll | |
|---|---|---|
| President, CEO, and Director | Mark Varney | |
| VP, CFO, and Corporate Secretary | Maria Messinger |